WANBURY
|
The Current P/B Ratio of WANBURY is 15.50.
Share Price | ₹279.3 | Jul 01,2025 |
Market Cap | ₹918.9 Cr | |
Book Value | ₹59.3 Cr | Mar2025 - Consolidated Results |
Price/Book | 15.50x | Calculated as MarketCap/Book Value |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PB (Price/Book ) ratio of WANBURY
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹918.9 Cr] as on Jul 01,2025
(/) Book Value [ ₹59.3 Cr] based on Mar2025 - Consolidated Results
(=) P/B Ratio [ 15.50x ]
Thus, for WANBURY , the investors are currently willing to pay '15.50 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of WANBURY !
The chart below summarizes the trend in P/B Ratio of WANBURY over the last five years.
Historical PB (Price/Book ) ratio chart of WANBURY
PB Ratio Performance Analysis for WANBURY
- WANBURY 's p/b ratio for fiscal years ending Mar2024 to Mar2020 averaged 1.24x.
- WANBURY 's operated at median p/b ratio of -1.33x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, WANBURY 's p/b ratio peaked in Mar2024 at 22.63x.
- WANBURY 's p/b ratio hit its five-year low in Mar2022 of -11.25x.
How does WANBURY 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
---|---|---|---|
WANBURY | 59.27 | 15.50 | 918.9 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 72,218.00 | 5.54 | 400,017.0 |
DIVIS LABORATORIES LTD | 14,969.00 | 12.15 | 181,867.0 |
CIPLA LTD | 31,079.30 | 3.94 | 122,451.0 |
TORRENT PHARMACEUTICALS LTD | 7,591.23 | 15.23 | 115,620.0 |
DR REDDYS LABORATORIES LTD | 33,404.90 | 3.19 | 106,572.0 |
MANKIND PHARMA LTD | 14,332.40 | 6.59 | 94,465.4 |
ZYDUS LIFESCIENCES LTD | 23,953.10 | 4.21 | 100,769.0 |
LUPIN LTD | 17,203.50 | 5.21 | 89,575.7 |
AUROBINDO PHARMA LTD | 32,653.30 | 2.01 | 65,775.8 |
ABBOTT INDIA LTD | 4,233.15 | 17.42 | 73,729.8 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs WANBURY 's P/B Ratio
Top 10 Industry Peers | PB Ratio |
---|---|
Min industry PB | 2.01x |
Max industry PB | 17.42x |
Median industry PB | 5.54x |
Average industry PB | 8.27x |
You may also like the below Video Courses